Australia: Precision-Guided Treatment Improves Outcomes for High-Risk Pediatric Cancer

Precision-guided treatment improves outcomes for children with high-risk cancer, according to a study published online June 6 in Nature Medicine.

Loretta M.S. Lau, M.B.B.S., Ph.D., from the Children’s Cancer Institute at the University of New South Wales Sydney, and colleagues reported data from 384 patients with high-risk pediatric cancer with at least 18 months of follow-up on the ZERO Childhood Cancer Precision Medicine Program PRecISion Medicine for Children with Cancer trial to examine which patients will benefit most from PGT. Overall, 67 and 29 percent of children received PGT recommendations and received a recommended treatment, respectively.

Source: Advances and More licensed by HealthDay

https://advancesandmore.com/advances_article.htm?id=YjUzYWJlZTMtYjg4MC00Y2FjLWI0NzMtNTNmMmI1ZDYyNTYx&client=Nw%3D%3D&section=undefined